Patents by Inventor Greg Hemmi

Greg Hemmi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8410263
    Abstract: Disclosed herein are the methods and compositions for the improved synthesis of texaphyrin metal complexes. The improved synthesis results in high-purity compositions of texaphyrin metal complexes in which more than about 98% of the texaphyrin metal complexes in the composition have the same structure and/or the same molecular weight. Further described herein are pharmaceutical compositions comprising such high-purity compositions, and the use of such high-purity compositions in the treatment of cancer and cardiovascular diseases and disorders.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: April 2, 2013
    Assignee: Pharmacyclics, Inc.
    Inventors: Hugo Madden, Greg Hemmi, Tarak Mody
  • Publication number: 20100048916
    Abstract: Disclosed herein are the methods and compositions for the improved synthesis of texaphyrin metal complexes. The improved synthesis results in high-purity compositions of texaphyrin metal complexes in which more than about 98% of the texaphyrin metal complexes in the composition have the same structure and/or the same molecular weight. Further described herein are pharmaceutical compositions comprising such high-purity compositions, and the use of such high-purity compositions in the treatment of cancer and cardiovascular diseases and disorders.
    Type: Application
    Filed: November 3, 2009
    Publication date: February 25, 2010
    Applicant: PHARMACYCLICS, INC.
    Inventors: Hugo MADDEN, Greg HEMMI, Tarak MODY
  • Patent number: 7579338
    Abstract: The radiation sensitization potential of a candidate compound can be screened by determine its ability to generate one or more reactive oxygen species under appropriate conditions. Compounds determined to have radiation sensitization potential are employed in methods for treating atheroma, tumors and other neoplastic tissue as well as other conditions that typically responsive to radiation sensitization.
    Type: Grant
    Filed: August 16, 2006
    Date of Patent: August 25, 2009
    Assignee: Pharmacyclics, Inc.
    Inventors: Jonathan L. Sessler, Darren Magda, Greg Hemmi, Tarak Mody
  • Patent number: 7547689
    Abstract: Compositions comprising motexafin gadolinium, as well as methods for using these compositions in the treatment of brain metastases, are described herein.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: June 16, 2009
    Assignee: Pharmacyclics, Inc.
    Inventors: Jonathan L. Sessler, Darren Magda, Norbert Purro, Tarak D. Mody, Greg Hemmi
  • Publication number: 20080063605
    Abstract: The invention relates to a method and a corresponding device for multipurposely supporting a randomly shaped and/or possibly complex with respect to a rigid base (11) part (1) by fixing a working reference, wherein the inventive method consist in interposing at least one deformable constant-volume chamber (3) which is sealed and filled with incompressible particles (4) between a maintainable part and the rigid base (11) and in lowing pressure inside the deformable constant-volume chamber (3) by means of a vacuum source (5) connectable thereto, thereby enabling the particles (4) to be amalgamated into a solid block which thrusts at least partly on the rigid base (11) and maintains the part (1) by fitting the shape thereof.
    Type: Application
    Filed: May 19, 2005
    Publication date: March 13, 2008
    Inventors: Wai-Fung Cheong, Hugo Madden, Greg Hemmi
  • Publication number: 20070072838
    Abstract: Disclosed herein are the methods and compositions for the improved synthesis of texaphyrin metal complexes. The improved synthesis results in high-purity compositions of texaphyrin metal complexes in which more than about 98% of the texaphyrin metal complexes in the composition have the same structure and/or the same molecular weight. Further described herein are pharmaceutical compositions comprising such high-purity compositions, and the use of such high-purity compositions in the treatment of cancer and cardiovascular diseases and disorders.
    Type: Application
    Filed: September 26, 2005
    Publication date: March 29, 2007
    Inventors: Hugo Madden, Greg Hemmi, Tarak Mody